Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125499071 | 12549907 | 1 | I | 201108 | 20160630 | 20160712 | 20160712 | EXP | US-PFIZER INC-2016333204 | PFIZER | 51.00 | YR | F | Y | 0.00000 | 20160712 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125499071 | 12549907 | 1 | SS | ENBREL | ETANERCEPT | 1 | UNK UNK, 2 TIMES/WK | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | BIW | |||||||||
| 125499071 | 12549907 | 2 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | Y | 203214 | TABLET | |||||||||
| 125499071 | 12549907 | 3 | SS | ORENCIA | ABATACEPT | 1 | UNK | Y | 0 | ||||||||||
| 125499071 | 12549907 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | UNK | Y | 0 | ||||||||||
| 125499071 | 12549907 | 5 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125499071 | 12549907 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125499071 | 12549907 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125499071 | 12549907 | Amnesia | |
| 125499071 | 12549907 | Anxiety disorder | |
| 125499071 | 12549907 | Blister | |
| 125499071 | 12549907 | Condition aggravated | |
| 125499071 | 12549907 | Coronary artery occlusion | |
| 125499071 | 12549907 | Drug hypersensitivity | |
| 125499071 | 12549907 | Gait disturbance | |
| 125499071 | 12549907 | Headache | |
| 125499071 | 12549907 | Injection site reaction | |
| 125499071 | 12549907 | Injection site swelling | |
| 125499071 | 12549907 | Intervertebral disc disorder | |
| 125499071 | 12549907 | Myocardial infarction | |
| 125499071 | 12549907 | Pneumonia | |
| 125499071 | 12549907 | Precancerous cells present | |
| 125499071 | 12549907 | Pustular psoriasis | |
| 125499071 | 12549907 | Pyrexia | |
| 125499071 | 12549907 | Rheumatoid arthritis | |
| 125499071 | 12549907 | Tooth abscess | |
| 125499071 | 12549907 | Transient ischaemic attack | |
| 125499071 | 12549907 | Vascular shunt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125499071 | 12549907 | 1 | 2001 | 0 |